The pharmacoepidemiological study of Zonisamide for Parkinson's disease
Phase 4
- Conditions
- Parkinson's Disease
- Registration Number
- JPRN-UMIN000026890
- Lead Sponsor
- Ehime University Graduate School of Medicine
- Brief Summary
The zonisamide use was significantly associated with a lower risk of dementia, insomnia, and gastric ulcers than 3 of 7 other classes without levodopa (p<.05).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9157
Inclusion Criteria
Not provided
Exclusion Criteria
1. Having only sub-category of G20; 3320001, 8830558, 8841415. 2. Secandary Parkinson's diseaase, which is defined as diagnosed with ICD-10 codes of G21, G22, and G23.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method